Pediatric to Adult Transition in Inflammatory Bowel Disease: Consensus Guidelines for Australia and New Zealand

Angharad Vernon-Roberts1, Patrick Chan2, Britt Christensen3

  • 1Department of Paediatrics, University of Otago, Christchurch, New Zealand.

PubMed

Insights

Rising pediatric inflammatory bowel disease (IBD) necessitates structured transition care. This study developed consensus statements for optimal adolescent to adult IBD care transition in Australasia.

Area of Science:

  • Gastroenterology
  • Pediatric Healthcare
  • Transition Medicine

Background:

  • Pediatric inflammatory bowel disease (IBD) incidence is increasing globally.
  • Adolescents with IBD require specialized support during their transition from pediatric to adult healthcare.
  • Significant variation exists in current transitional care practices for IBD across Australasia.

Purpose of the Study:

  • To develop evidence and expert opinion-based consensus statements.
  • To guide the establishment and improvement of transitional care services for adolescents with IBD.
  • To standardize care delivery for pediatric to adult IBD transitions in Australasia.

Main Methods:

  • Utilized a modified UCLA-RAND methodology for consensus development.
  • Conducted a systematic literature review and formed an expert steering committee.
  • Engaged a multidisciplinary group (16 participants) and patient support groups, including young people with IBD, for anonymous voting and feedback.

Main Results:

  • Developed 14 consensus statements with high median ratings for appropriateness (≥8) and necessity (≥7).
  • Key recommendations include structured transition programs, dedicated transition coordinators, and readiness assessments.
  • Included focus on mental health, adolescent-specific discussion topics, allied health involvement, and optimized clinical handover.

Conclusions:

  • Consensus statements were devised by a multidisciplinary group to optimize pediatric to adult transitional care for adolescents with IBD.
  • These guidelines aim to support improved and standardized delivery of IBD transitional care services.
  • Implementation of these statements is expected to enhance patient outcomes during the critical transition period.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
127
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
145
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
222
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
160
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
172